Dawi, J.; Tumanyan, K.; Tomas, K.; Misakyan, Y.; Gargaloyan, A.; Gonzalez, E.; Hammi, M.; Tomas, S.; Venketaraman, V.
Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies. Biomedicines 2025, 13, 1076.
https://doi.org/10.3390/biomedicines13051076
AMA Style
Dawi J, Tumanyan K, Tomas K, Misakyan Y, Gargaloyan A, Gonzalez E, Hammi M, Tomas S, Venketaraman V.
Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies. Biomedicines. 2025; 13(5):1076.
https://doi.org/10.3390/biomedicines13051076
Chicago/Turabian Style
Dawi, John, Kevin Tumanyan, Kirakos Tomas, Yura Misakyan, Areg Gargaloyan, Edgar Gonzalez, Mary Hammi, Serly Tomas, and Vishwanath Venketaraman.
2025. "Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies" Biomedicines 13, no. 5: 1076.
https://doi.org/10.3390/biomedicines13051076
APA Style
Dawi, J., Tumanyan, K., Tomas, K., Misakyan, Y., Gargaloyan, A., Gonzalez, E., Hammi, M., Tomas, S., & Venketaraman, V.
(2025). Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies. Biomedicines, 13(5), 1076.
https://doi.org/10.3390/biomedicines13051076
